Mark E. Dunlap, MD - Department of Physiology and Biophysics

Mark E. Dunlap, MDCurriculum Vitae, page 27April 2006April 2006May 2006July 2006July 2006September 2006September 2006September 2006October 2006October 2006October 2006October 2006October 2006November 2006November 2006November 2006December 2006“Hospitalization and Discharge of the Heart Failure Patient”Live video broadcast (video-taped and re-broadcast online)Sponsored by the Department of Veterans Affairs and by the Annenberg Centerhttp://www.5starmeded.com/_rc/rc89.html“Functional Class, Quality of Life, and 6 Minute Walk test in heart failure patients withlow vs. preserved systolic function: Baseline data from HearT-I”Research ShowCASE, sponsored by Case Western Reserve University, Cleveland, Ohio“Acute Decompensated Heart Failure: An Updated Management”2 nd International Meeting of Atherothrombosis & Panvascular Intervention of GuadalajaraGuadalajara, Mexico"Utilization of Beta Blockade in Patients with Potential Contraindications"Amelia Island Heart Failure Update (sponsored by University of North Carolina)“How to Conduct Shared Medical Appointments for HF Patients”Amelia Island Heart Failure Update (sponsored by University of North Carolina)"How to use Beta Blockade in Patients with Potential Contraindications"‘How to Session”, Heart Failure Society of America Scientific Sessions, Seattle, Washington“Alterations of the parasympathetic nervous system in HF:does restoration slow disease progression?”Cardiology Grand Rounds, Univ. of Colorado Health Sciences Center, Denver, Colorado“New Guideline Recommendations for HF Management: Implications for Clinical Practice”Cardiology Updates, Los Angeles“Improving Outcome in HF: New Insights from Vascular Biology”Medical Grand Rounds, WRCS Forum Health, Northside Medical Center, Youngstown, OH“Contemporary management of the HF patient with co-morbidities:can't sleep, can't breathe, can't pee”Cardiology Grand Rounds, MetroHealth Medical Center, Cleveland, Ohio“Update on the Treatment of Heart Failure”CCH Providers Retreat, MetroHealth System, Cleveland, Ohio“Cardiac Monitoring Devices for CHF: are noninvasive alternatives just as good?”Cardiac Monitoring Devices for CHF, invited speaker and panel memberTranscatheter Cardiovascular Therapeutics Annual Meeting, Washington, DC“Implications of Risk Factor Reduction: Clinical Trials and Meta-Analyses” and“Pharmacologic Differences Among -blockers: Recent Trials in Hypertension and HF”Symposium entitled “Clarifying the Role of Beta-Blockers in theHypertension Treatment Paradigm’, Miami, Florida“Heart Failure: Exactly What is Failing and What Can We Do About It?’Medicine Grand Rounds, MetroHealth Medical Center, Cleveland, OH“Preserving Ventricular Function in HF”; AHA CME Satellite Symposium entitled“Targeting Novel Mechanisms in the Management of Cardiovascular Risk”Chicago, Illinois; Peter Libby, MD, Chair“Heart Failure Across the Ages”; theheart.org. [Satellite programs (CME) > Spotlight];Panel with Thomas Giles MD, Philip A Poole-Wilson MD, and Clyde W Yancy MDWebcast: http://www.theheart.org/article/752851.do“1-Cardioselective beta blockers for Management of Hypertension and HF:Evidence-based Reviews of the Current Literature and Recent Clinical Trials”Invited Speaker and Moderator